Stories & Insights

Tracking PFAS in the Global Supply Chain

Trexin helped a large MedTech leader survey its suppliers to fully inventory the presence of “forever chemicals” in their products.

Mitigating Third-Party Risks

Trexin conducted a comprehensive risk assessment of a health insurance subsidiary’s cybersecurity controls and resilience strategies.

Developing a Low-Cost Systemic Approach for Data Normalization

Trexin created an MDM-lite solution with process automation and faster data ingestion to enhance usability, accuracy, and workflow efficiency.

Glenn Kapetansky Elevated to Senior Member Status with Institute of Electrical and Electronics Engineers

Trexin Consulting, a national management consulting and technology solutions firm specializing in digital strategy execution, announced today that Glenn Kapetansky has been elevated to Senior Member status with the Institute of Electrical and Electronics Engineers (IEEE).

Data & Artificial Intelligence (AI)

Level 200: Beyond Basic Use Cases of AI – How to Unlock Potential

On March 6th, Bo Youman, Justin Dale, Abdullahi Hashi, and Brendan Kanwischer attended Applied AI’s “Level 200: Beyond Basic Use Cases of AI – How to Unlock Potential” event.

Data & Artificial Intelligence (AI) | Digital Transformation | Financial Services | Healthcare & Life Sciences | MedTech | Program Execution | Strategy Execution

Ed Letcher Promoted to Senior Principal

Trexin Consulting, a national management consulting and technology solutions firm specializing in digital strategy execution, announced today that Ed Letcher has been promoted to Senior Principal.

Analytics | Data & Artificial Intelligence (AI) | Healthcare & Life Sciences | Optimized Operations | Strategy & Innovation

Winning the IDR Battle: The Optimal Offer Strategy Through the Plan/Issuer Lens

Justin Martin shares helpful information regarding the Independent Dispute Resolution (IDR) Process and the No Surprises Act.

Healthcare & Life Sciences | MedTech | Optimized Operations | Products & Distribution | Strategy & Innovation

PFAS Regulations in 2025 and Beyond

Kenneth Beymer examines the new and updated state-level PFAS regulations beginning in 2025.

Data & Artificial Intelligence (AI) | Healthcare & Life Sciences | Optimized Operations | Technology

Exploring the Risks and Implications of CMS Final Rule 0057: Interoperability and Prior Authorization

Asim Jeelani provides information on the risks and implications of CMS Final Rule 0057 as well as effective strategies to mitigate the risks.